TY - JOUR
AU - Seibert,, G.
AB - Abstract The in-vitro activity of cefpiromc, a new injectable cephalosporin, was compared with that of several other antibiotics against bacterial isolates from hospitalized patients with lower respiratory tract infections, urinary tract infections and wound infections. Minimum inhibitory concentrations were determined for 874 strains against 16 antibiotics using a microtitration technique. Cefpirome showed a very broad spectrum of activity against most pathogens tested. The spectrum included organisms such as Staphylococcus spp., enterococci, Enterobacter spp., and Pseudomonas spp. which are frequently resistant to third generation cephalosporins. This content is only available as a PDF. Author notes * Study group: Dr Schäfer, Hygiene Institute, Frankfurt/M. Univenity Hospital, Germany, Dr Lehtonen, PULSSI, Turku, Finland; Dr Rylander, Department of Microbiology, Karolinska Hospital, Stockholm, Sweden; Dr Georgopoulos, Vienna General Hospital, University Chemotherapy Department, Vienna, Austria; Prof Mimica, Hospital Santa Casa Misericordia, Microbiological Laboratory, Säo Paulo, Brazil; Dr Rockstroh, Institute for Infectious Diseases, Berlin-Buch, Germany; BARC, Ghent, Belgium. © 1992 The British Society for Antimicrobial Chemotherapy
TI - In-vitro activity of cefpirome against isolates from patients with urinary tract, lower respiratory tract and wound infections
JF - Journal of Antimicrobial Chemotherapy
DO - 10.1093/jac/29.suppl_A.7
DA - 1992-01-01
UR - https://www.deepdyve.com/lp/oxford-university-press/in-vitro-activity-of-cefpirome-against-isolates-from-patients-with-ksHrTYPLnB
SP - 7
EP - 12
VL - 29
IS - suppl_A
DP - DeepDyve
ER -